► Hypertrophic Cardiomyopathy: In this condition the heart muscles get thicker making it harder for blood to leave.
► Dilated Cardiomyopathy: Weakening and enlargement of the heart muscles prevent it from pumping blood efficiently.
► Restrictive Cardiomyopathy: This condition is associated with increased stiffness of the heart.
Symptoms include palpitation. difficulty with breathing (dyspnoea) and sometimes even Sudden death can occur, Complications like pulmonary oedema, arrhythmias and ascites can occur.
Sudden cardiac death is the most dreaded of the complications. International guidelines recommend that a risk stratification score can predict the outcome. These are the six risk factors to look for in a patient with Cardiomyopathy:
► Previous cardiac arrest or sustained ventricular tachycardia,
► Non-sustained ventricular tachycardia,
► Extreme left ventricular hypertrophy,
► Unexplained syncope,
► Abnormal blood pressure response,
► Family history of sudden death
Treatment and outlook of Cardiomyopathy depends on a number of factors like cause & type of Cardiomyopathy. Heart transplant is a treatment option for selected patients with hypertrophic Cardiomyopathy (HCM).
Latest Publication and Research on CardiomyopathyTNNT2 Gene Polymorphisms Are Associated with Susceptibility to Idiopathic Dilated Cardiomyopathy in the Han Chinese Population. - Published by PubMed
Takotsubo Cardiomyopathy following a L2-L5 Laminectomy and Fusion In Situ with Bone Morphogenic Protein. - Published by PubMed
Palmitate Diet-induced Loss of Cardiac Caveolin-3: A Novel Mechanism for Lipid-induced Contractile Dysfunction. - Published by PubMed
Dissociation Between Severity of Takotsubo Cardiomyopathy and Presentation With Shock or Hypotension. - Published by PubMed
Chronic Administration of Small Non-Erythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Post Myocardial Infarction Dilated Cardiomyopathy. - Published by PubMed